Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rFVIIa for Peri-operative Blood Loss in Burn Excision
NCT00243243Phase 3Completed
- Sponsor
- U.S. Army Institute of Surgical Research
- Start
- Jan 2006
- Primary completion
- Jun 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of coagulation factor VIIa in burn injury, sponsored by U.S. Army Institute of Surgical Research. Started Jan 2006; status: completed.
02
Drugs
coagulation factor VIIa
03
Conditions
burn injury
Beyond the preview
Go deeper on NCT00243243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00243243.